488
edits
m (Bot: adding archive links to references (error log).) |
No edit summary Tag: 2017 source edit |
||
Line 1: | Line 1: | ||
{{content warning|private body parts, puberty, and menstruation}} | {{content warning|private body parts, puberty, and menstruation}} | ||
{{disclaimer| | {{disclaimer|medical}} | ||
'''Puberty blockers''', also called '''puberty inhibitors''', are drugs used to postpone and temporarily suspend puberty in [[children]] and teenagers. These drugs are called gonadotropin-releasing hormone (GnRH) agonists, and they inhibit the action of [[testosterone]]. Delaying or temporarily suspending puberty is a medical treatment for children whose puberty started abnormally early (precocious puberty). The drugs are also commonly used for children with idiopathic short stature, for whom these drugs can be used to promote development of long bones and increase adult height.<ref>Sara E. Watson, Ariana Greene, Katherine Lewis, and Erica A. Eugster (2015). Bird's-eye view of GnRH analog use in a pediatric endocrinology referral center. ''Endocrine Practice:'' June 2015, Vol. 21, No. 6, pp. 586-589.</ref> Additionally, they are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal|last=Stevens|first=Jaime|last2=Gomez-Lobo|first2=Veronica|last3=Pine-Twaddell|first3=Elyse|date=2015-12-01|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth|url=http://pediatrics.aappublications.org/content/136/6/1029|journal=Pediatrics|language=en|volume=136|issue=6|pages=1029–1031|doi=10.1542/peds.2015-2849|issn=0031-4005|pmid=26527547|doi-access=free|archive-url=https://web.archive.org/web/20230628170532/http://pediatrics.aappublications.org/content/136/6/1029|archive-date=17 July 2023}}</ref><ref>{{cite web |url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ |title=Looking at suppressing puberty for transgender kids |publisher=Associated Press |date=March 12, 2016|archive-url=https://web.archive.org/web/20230617205749/http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ |archive-date=17 July 2023 }}</ref><ref>{{cite web |url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ |title=Transgender Youth Using Puberty Blockers |publisher=[[KQED]] |date=August 19, 2016|archive-url=https://web.archive.org/web/20221211205947/https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ |archive-date=17 July 2023 }}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal|last=Alegría|first=Christine Aramburu|date=2016-10-01|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice|journal=Journal of the American Association of Nurse Practitioners|language=en|volume=28|issue=10|pages=521–527|doi= 10.1002/2327-6924.12363|pmid=27031444|issn=2327-6924}}</ref> | '''Puberty blockers''', also called '''puberty inhibitors''', are drugs used to postpone and temporarily suspend puberty in [[children]] and teenagers. These drugs are called gonadotropin-releasing hormone (GnRH) agonists, and they inhibit the action of [[testosterone]]. Delaying or temporarily suspending puberty is a medical treatment for children whose puberty started abnormally early (precocious puberty). The drugs are also commonly used for children with idiopathic short stature, for whom these drugs can be used to promote development of long bones and increase adult height.<ref>Sara E. Watson, Ariana Greene, Katherine Lewis, and Erica A. Eugster (2015). Bird's-eye view of GnRH analog use in a pediatric endocrinology referral center. ''Endocrine Practice:'' June 2015, Vol. 21, No. 6, pp. 586-589.</ref> Additionally, they are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal|last=Stevens|first=Jaime|last2=Gomez-Lobo|first2=Veronica|last3=Pine-Twaddell|first3=Elyse|date=2015-12-01|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth|url=http://pediatrics.aappublications.org/content/136/6/1029|journal=Pediatrics|language=en|volume=136|issue=6|pages=1029–1031|doi=10.1542/peds.2015-2849|issn=0031-4005|pmid=26527547|doi-access=free|archive-url=https://web.archive.org/web/20230628170532/http://pediatrics.aappublications.org/content/136/6/1029|archive-date=17 July 2023}}</ref><ref>{{cite web |url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ |title=Looking at suppressing puberty for transgender kids |publisher=Associated Press |date=March 12, 2016|archive-url=https://web.archive.org/web/20230617205749/http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ |archive-date=17 July 2023 }}</ref><ref>{{cite web |url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ |title=Transgender Youth Using Puberty Blockers |publisher=[[KQED]] |date=August 19, 2016|archive-url=https://web.archive.org/web/20221211205947/https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ |archive-date=17 July 2023 }}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal|last=Alegría|first=Christine Aramburu|date=2016-10-01|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice|journal=Journal of the American Association of Nurse Practitioners|language=en|volume=28|issue=10|pages=521–527|doi= 10.1002/2327-6924.12363|pmid=27031444|issn=2327-6924}}</ref> | ||